Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB vs NATAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NATALIZUMAB vs NATAMYCIN: Safety Overview

Metric NATALIZUMAB NATAMYCIN
Total FAERS Reports 64,315 258
Deaths Reported 3,140 61
Death Rate 4.9% 23.6%
Hospitalizations 17,879 101
Average Patient Age 45.6 yrs 57.9 yrs
% Female Patients 78.5% 50.0%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Sandoz Inc Harrow Eye, LLC
Route INTRAVENOUS OPHTHALMIC
Marketing Status Prescription Prescription